Risk factors for severe infections during induction therapy of patients with microscopic polyangiitis | Synapse
April 5, 2026
Risk factors for severe infections during induction therapy of patients with microscopic polyangiitis
Key Points
To identify risk factors for severe infections during induction therapy in patients with microscopic polyangiitis.
Analyzed patient history and treatment regimens for those diagnosed with microscopic polyangiitis.
Documented the incidence of severe infections during glucocorticoid therapy.
Evaluated the impact of chronic lung disease on infection rates.
Higher dosage of glucocorticoids correlates with an increased risk of severe infections.
Patients with a history of chronic lung disease show a higher incidence of infections.
Abstract
MPA is associated with a high risk of severe infections, especially in patients treated with higher dosage glucocorticoid and with a history of chronic lung disease.